Emerging drugs for diabetic neuropathy
Authors:
- Abd A TahraniATAbd A Tahrani
- Trevor AskwithTATrevor Askwith
- Martin J StevensMSMartin J Stevens
- 15 July 2010
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Emerging Drugs
- Vol. 15 (4) , 661-683
Abstract
(2010). Emerging drugs for diabetic neuropathy. Expert Opinion on Emerging Drugs: Vol. 15, No. 4, pp. 661-683. doi: 10.1517/14728214.2010.512610Keywords
This publication has 172 references indexed in Scilit:
- Olesoxime (cholest-4-en-3-one, oxime): Analgesic and neuroprotective effects in a rat model of painful peripheral neuropathy produced by the chemotherapeutic agent, paclitaxelPain, 2009
- Alpha-lipoic acid as a dietary supplement: Molecular mechanisms and therapeutic potentialBiochimica et Biophysica Acta (BBA) - General Subjects, 2009
- Effects of Prior Intensive Insulin Therapy on Cardiac Autonomic Nervous System Function in Type 1 Diabetes MellitusCirculation, 2009
- Efficacy and Safety of Lacosamide in Diabetic Neuropathic PainThe Clinical Journal of Pain, 2009
- Elevated Triglycerides Correlate With Progression of Diabetic NeuropathyDiabetes, 2009
- Treatment of Zucker diabetic fatty rats with AVE7688 improves vascular and neural dysfunctionDiabetes, Obesity and Metabolism, 2009
- Gabapentin Versus Tricyclic Antidepressants for Diabetic Neuropathy and Post-Herpetic Neuralgia: Discrepancies Between Direct and Indirect Meta-Analyses of Randomized Controlled TrialsJournal of General Internal Medicine, 2008
- Protein Kinase C Function in Muscle, Liver, and β-Cells and Its Therapeutic Implications for Type 2 DiabetesDiabetes, 2008
- Efficacy, Safety, and Tolerability of Pregabalin Treatment for Painful Diabetic Peripheral NeuropathyDiabetes Care, 2008
- PARP inhibition or gene deficiency counteracts intraepidermal nerve fiber loss and neuropathic pain in advanced diabetic neuropathyFree Radical Biology and Medicine, 2008